Gafen

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Gafen

Property Description
Active Ingredient Gabapentin
Form Capsule, tablet, oral solution
Pharmacological Class Anticonvulsant, Anti-epileptic drug
General Purpose Stabilizing nerve activity
Origin Synthetic

What is Gafen and How is it Classified?

Gafen is a prescription medication whose active component is the synthetic substance Gabapentin. It is classified as an anticonvulsant or anti-epileptic drug and is recognized as a central nervous system agent. Gabapentin is clinically recognized for its role in managing conditions characterized by excessive neuronal firing.

Gabapentin is a single-ingredient product known by its chemical structure as 1-(Aminomethyl)cyclohexaneacetic acid. This molecule is distinct from direct GABA enhancers, although it is a structural analogue of the inhibitory neurotransmitter GABA (gamma-aminobutyric acid). Its classification as an anti-epileptic drug emphasizes its unique ability to modulate nerve signal transmission.


Composition, Forms, and Origin of Gabapentin

The core of Gafen is the chemically synthetic Gabapentin molecule, which is combined with standard pharmaceutical excipients necessary for the final preparation.

Gabapentin is manufactured through chemical synthesis, which ensures the highest purity and consistency necessary for a medicine that affects the central nervous system. It is primarily administered via the oral route and is available in several dosage forms, including standard capsules, compressed tablets, a liquid oral solution, and specialized extended-release tablet formulations. The availability of liquid and varied tablet forms addresses different patient needs, such as pediatric patients or those requiring a specific dosing regimen.


General Purpose and Action Principle

The general purpose of Gafen is to promote neural stability by helping to quiet overactive nerves and stabilize nerve cell communication.

This general effect is achieved by the drug binding to an auxiliary subunit (alpha2delta) on certain voltage-activated calcium channels in neurons. This action subtly dampens the nerve's ability to release excessive excitatory signals, which are often the cause of disorganized electrical activity. By reducing overall neuronal excitability, the medicine helps establish a more balanced neural environment in the central nervous system. This function relates to the medicine's fundamental ability to calm heightened nerve activity.

What side effects are possible with Gafen?

Possible Side Effects and Safety Information

The officially documented safety profile of Gafen, whose active ingredient is Gabapentin, is primarily defined by effects on the Central Nervous System (CNS) and mandatory warnings for serious systemic reactions, consistent with its classification as an anti-epileptic drug.


Frequency-Classified Adverse Reactions

Adverse reactions are organized into frequency categories based on regulatory documents (e.g., EMA/FDA):

  • Very Common (Affecting ge 1 in 10 individuals): The most frequently documented effects are dizziness and somnolence (drowsiness).
  • Common (Affecting ge 1 in 100 individuals): These include ataxia (incoordination), fatigue, peripheral swelling (oedema), headache, tremor, and weight gain. Behavioral changes, such as hostility, are also listed as common in pediatric patients aged 3 to 12 years.

Serious Adverse Reactions and Safety Constraints

The regulatory label highlights several reactions classified as serious or clinically significant:

  • Severe Cutaneous Adverse Reactions (SCARs): These are rare but life-threatening skin reactions, including Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) and Stevens-Johnson syndrome (SJS).
  • Suicidal Behavior and Ideation: There is a documented increased risk of suicidal thoughts and behavior associated with the use of all anti-epileptic drugs.
  • Respiratory Depression: Serious breathing difficulties are a documented risk, especially when Gabapentin is co-administered with other CNS depressants, such as opioids, or in individuals with underlying respiratory issues.

Population-Specific Safety Notes

The official documents include specific safety considerations for certain patient groups:

  • Renal Impairment: Due to its primary clearance by the kidneys, the regulatory documents mandate a dose adjustment for individuals with reduced renal function.
  • Older Adults: This population may be more susceptible to common effects like dizziness and somnolence, and caution is advised due to the common prevalence of reduced kidney function in this age group.

Abrupt discontinuation of Gafen in patients being treated for seizure disorders is explicitly noted to carry a risk of precipitating seizures or status epilepticus, highlighting an important safety pattern tied to the cessation of use.

Overdose and Emergency Response

The regulatory documentation defines the acute overdose profile for Gafen (Gabapentin) based on central nervous system (CNS) depression and motor function impairment. Documented manifestations of overexposure include signs such as slurred speech, drowsiness, lethargy, and double vision. Severe overexposure is associated with outcomes including coma and fatal respiratory depression.

The risk of serious or life-threatening breathing difficulties is explicitly heightened when Gafen is taken concurrently with other CNS depressants, such as opioids. Regulator-mandated warnings also highlight an increased risk of severe outcomes for elderly patients and those with underlying respiratory impairment or significant renal impairment.

When to Seek Help and Management

The official statement requires individuals to seek immediate medical attention for any symptoms of respiratory distress, including slow or shallow breathing, unresponsiveness, or confusion. In cases of overexposure, individuals should contact a poison control center immediately.

Management is restricted to symptomatic and supportive treatment, as regulatory information confirms that no specific antidote is known. The drug may be removed by hemodialysis if clinically indicated, particularly in patients with severe renal impairment.

Therapeutic Uses of Gafen

What Gafen Treats: Main Uses and Benefits

This medication is applied across domains where the patient experiences symptoms related to heightened neurological activity. It is commonly used to help manage conditions characterized by recurrent or episodic manifestations. Established uses include providing supportive relief for Chronic Neuropathic Pain (such as Postherpetic Neuralgia), serving as adjunctive therapy for Partial Onset Seizures, and assisting with Moderate-to-Severe Restless Legs Syndrome (RLS).

The primary therapeutic purpose relates to managing symptoms of increased neurological or muscular activity, which supports the patient during difficult episodes by easing distress. It is applied in clinical settings marked by significant symptomatic discomfort, often when symptoms become more noticeable at night or persist chronically.

“It provides support that helps ease the overall symptom load linked to shooting, burning, and stabbing nerve pain, and may assist with maintaining functional stability for seizure control.”

By addressing symptom clusters that interfere with daily comfort, the medication supports general well-being and may help patients cope more steadily with symptom fluctuations.


Quick Fact: Relief for Neuropathic Discomfort and Seizure Activity

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Gafen, which contains the active ingredient ibuprofen, is a non-steroidal anti-inflammatory drug (NSAID) primarily used for its pain-relieving, fever-reducing, and anti-inflammatory effects. It is generally suitable for most adults and children over a specific age, depending on the formulation, when used correctly for approved indications.

However, there are important conditions and circumstances where Gafen should not be used (contraindications), as the risk of serious side effects outweighs the potential benefit. Patients should consult a healthcare professional before use if they have certain pre-existing conditions or are taking specific medications.

Who Can Generally Use Gafen Who Cannot (Contraindications)
Most adults and older children History of allergic reaction to aspirin or other NSAIDs
For mild-to-moderate pain, fever, and inflammation Active gastrointestinal bleeding or peptic ulcer
Severe heart failure, kidney failure, or liver failure
Coronary artery bypass graft (CABG) surgery (before or immediately after)
Last trimester of pregnancy

Caution is also advised for patients with a history of stomach ulcers, bleeding disorders, hypertension, asthma, or those concurrently taking anticoagulants (like warfarin) or low-dose aspirin for heart protection, as this increases the risk of adverse events.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Gafen (Gabapentin) is documented by regulatory authorities to have specific interaction patterns, primarily involving additive central nervous system (CNS) effects and altered drug exposure, rather than hepatic metabolism.

Pharmacokinetic and Pharmacodynamic Interactions

Coadministered Substance/Class Interaction Type/Outcome Administration Constraint
Antacids (Aluminum/Magnesium) Pharmacokinetic: Reduces Gabapentin bioavailability by approximately 20%. Mandatory Timing Rule: Must be taken at least 2 hours following the antacid.
CNS Depressants (including Opioids and Alcohol) Pharmacodynamic: Additive effects leading to increased risk of sedation and respiratory depression. Requires careful observation due to risk of serious adverse reactions.
Cimetidine Pharmacokinetic: Reduces Gabapentin renal clearance by approximately 12%. Affects systemic exposure.

Gabapentin is documented as being not appreciably metabolized by the liver and does not significantly interfere with the metabolism of other coadministered anti-epileptic drugs. Clearance may be reduced in individuals with renal dysfunction, leading to documented concerns of accumulation. Furthermore, Gabapentin may cause false positive results when testing for urinary protein using the Ames N-Multistix SG® dipstick test.

Mechanism of Action

Targeted Modulation of Presynaptic Calcium Channels

Gabapentin achieves its action by binding specifically to the auxiliary subunit alpha2delta-1 of voltage-gated calcium channels (VGCCs) located on the presynaptic nerve terminals. This high-affinity interaction functionally disrupts the alpha2delta subunit's ability to facilitate the movement (trafficking) of these channels to the cell surface, resulting in a crucial limitation of calcium influx.

Mechanism of Neural Signal Modulation

The restriction of calcium influx reduces the chemical trigger necessary for synaptic vesicles to release their contents, thus dampening the output of excitatory neurotransmitters such as Glutamate. This functional inhibition of excessive excitatory signaling ultimately modulates nerve communication patterns, reducing the propagation of excessive electrical signaling throughout the affected central and spinal pathways. The resulting physiological consequence is the attenuation of hyper-responsive activity within these nerve circuits.

Dosage and Administration Information

Gafen is a medication containing ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), and should be taken exactly as prescribed by a healthcare provider or as directed on the product label.

General Administration Instructions

  • Take Orally: Swallow tablets or capsules whole with a full glass of water (8 ounces or 240 milliliters). Do not chew, crush, or break extended-release forms unless specifically instructed.
  • With Food or Milk: To minimize the risk of gastrointestinal upset, Gafen is generally recommended to be taken with food, milk, or an antacid. However, taking the dose on an empty stomach may lead to faster pain relief.
  • Timing: For best results, use Gafen at the onset of pain. If taking it on a regular schedule, try to take doses at the same time each day.
  • Post-Dose Posture: After taking an oral dose, remain upright (do not lie down) for at least 10 minutes.

Dosage and Duration

To reduce the risk of serious side effects, always use the lowest effective dose for the shortest necessary duration. Do not exceed the maximum daily dose recommended by your doctor or the package labeling.

Patient Group Dosing Principle
Adults Dosing depends on the condition (e.g., pain, fever, arthritis) and is typically every 4 to 6 hours as needed. The maximum daily dosage for adults is generally 3200 mg/day for prescription use, but often lower for over-the-counter products.
Children Dosing for children, especially those under 12, is based on body weight and age and must be determined by a healthcare professional. Use the measuring device provided with liquid formulations for accurate dosing.

Missed Dose

If you are taking Gafen on a regular schedule and miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed one and continue with your regular dosing schedule. Do not double the dose to make up for a missed one.

Recent Clinical Evidence

Research evidence / Overview of studies

Evidence for Osteoarthritis Research

Clinical studies focusing on Drug X have evaluated whether it influences joint function and affects chronic pain symptoms, including those associated with knee and hip osteoarthritis. This compound remains a subject of ongoing research for patients with osteoarthritis.

Research has investigated whether it affects inflammation markers, such as C-reactive protein (CRP). Early-stage studies have explored whether the standard 10mg daily dose is associated with outcomes similar to those assessed in established therapies, though direct comparisons are limited. Investigators are studying whether this approach may offer a difference for patient cohorts who have not responded to traditional therapies.


Safety and Protocol Summary

The most frequent events reported in study tolerability sections included gastrointestinal discomfort and headache. Study protocols stipulated administration with food, and trials involved a mean duration of 12 weeks.

A small number of studies tracked liver enzyme levels, and while the majority of participants experienced no changes, a few trials reported instances of increased liver enzyme levels. Study design generally featured the exclusion of participants with significant kidney or liver impairment. Protocols also commonly included the monitoring of participants with cardiovascular conditions.


Combination Therapy Research

Research has compared the combination of Drug X and Physical Therapy to either treatment alone in trials evaluating outcomes related to mobility and a return to daily activities. These trials often used standardized measures like the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) to assess function and pain levels.


Biological Activity Research

Studies have investigated the drug's activity, which included exploration of the NF-kappa B pathway. Biological models, including in vitro and animal studies, have been used in ongoing research.

Key Studies & References ACR/EULAR Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee

Frequently Asked Questions (FAQ)

Common questions about Gafen (FAQ)

Q: What is Gafen used for?

Gafen is used for the temporary relief of minor aches and pain associated with conditions such as headaches, toothaches, muscular aches, backache, minor pain from arthritis, and menstrual cramps (dysmenorrhea). It is also used to reduce fever.


Q: How does Gafen work to relieve pain and fever?

Gafen contains the active ingredient ibuprofen, which is a type of medicine known as a Non-Steroidal Anti-Inflammatory Drug (NSAID). Ibuprofen works by blocking the production of certain natural substances in the body that cause inflammation, pain, and fever. By inhibiting these substances, Gafen helps to reduce both pain sensation and elevated body temperature.


Q: What should I know before taking Gafen?

Before taking Gafen, you should consult a healthcare professional if you have a history of conditions such as:

  • Stomach ulcers or bleeding in the stomach or intestines.
  • Asthma or bronchospasm, especially if it is worsened by aspirin or other NSAIDs.
  • Heart failure, severe liver failure, or severe kidney failure.
  • Coagulopathy (a bleeding disorder).

It's important to not take Gafen if you have a known hypersensitivity or allergic reaction (like asthma, hives, or facial swelling) to ibuprofen, aspirin, or any other NSAIDs.


Q: Can Gafen be taken with other medicines?

Do not take Gafen with other non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin. Using Gafen with these medicines increases the risk of side effects, particularly on the stomach and intestines, such as bleeding and ulcers.

Always inform your doctor or pharmacist about all other medicines, supplements, or herbal products you are taking to check for potential drug interactions.


Q: What are the common side effects of Gafen?

The most frequent side effects of Gafen involve the gastrointestinal tract, which may include irritation of the stomach lining, stomach ache, bloating, or diarrhea. Other common side effects may include headache, dizziness, nausea, and vomiting. If you experience mild digestive side effects, taking the medicine with food or milk may help.

If you develop signs of a severe allergic reaction, such as difficulty breathing, a rash, hives, or swelling of the face, stop taking the medicine immediately and seek urgent medical attention.

How should Gafen be stored and disposed of?

The storage and disposal of Gafen (Gabapentin) must comply strictly with official regulatory requirements to ensure product stability and environmental safety.

Requirement Official Rule (Regulatory Basis)
Temperature Store capsules/tablets at Controlled Room Temperature (typically 20 C to 25 C), with excursions permitted to 15 C to 30 C (FDA Label). Liquid oral solution must be refrigerated but not frozen.
Packaging Keep the medication in its original, tightly closed container; half-tablets of scored formulations must be discarded if not used within 28 days (FDA Label).
Child Safety The product must be stored out of the sight and reach of children (Universal Mandatory Rule).
Disposal Do not dispose of unused medicine in household trash or wastewater. Disposal should follow official guidelines, such as drug take-back programs or pharmacy-led collection.

In regions where Gabapentin is classified as a Controlled Drug (e.g., UK), specialized denaturing protocols may be required to render unused or expired medicine irretrievable prior to disposal in the pharmaceutical waste stream.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Gafen found in:

A-Z Index: